Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Waters CFO Sherry Buck stepping down December 31 » 07:02
12/03/20
12/03
07:02
12/03/20
07:02
WAT

Waters

$234.81 /

+0.39 (+0.17%)

Waters CFO Sherry Buck…

Waters CFO Sherry Buck will step down effective December 31 in order to pursue another opportunity at a privately held company. Upon her departure, Michael Silveira, VP and Corporate Controller of Waters, will assume the role of interim CFO. Buck will work alongside Silveira in order to facilitate a smooth transition. Waters has been working with a search firm to identify a permanent CFO, and the process is advancing well with several internal and external candidates. Silveira joined Waters in 2004 as Assistant Corporate Controller. He has held several senior financial management positions with Astro-Med, Textron and KPMG.

ShowHide Related Items >><<
WAT Waters
$234.81 /

+0.39 (+0.17%)

WAT Waters
$234.81 /

+0.39 (+0.17%)

12/02/20 Goldman Sachs
Waters initiated with a Neutral at Goldman Sachs
11/09/20 KeyBanc
Waters initiated with a Sector Weight at KeyBanc
10/28/20 Citi
Waters price target raised to $185 from $180 at Citi
07/29/20 SVB Leerink
Waters price target raised to $225 from $195 at SVB Leerink
WAT Waters
$234.81 /

+0.39 (+0.17%)

WAT Waters
$234.81 /

+0.39 (+0.17%)

Wednesday
Initiation
Waters initiated with a Neutral at Goldman Sachs » 05:05
12/02/20
12/02
05:05
12/02/20
05:05
WAT

Waters

$234.15 /

+2.185 (+0.94%)

Goldman Sachs analyst…

Goldman Sachs analyst Matthew Sykes initiated coverage of Waters with a Neutral rating and $230 price target. The analyst believes the Life Sciences Tools and Diagnostics sector will continue to outperform the overall market due to the combination of "resilient business models and multiple secular growth tailwinds." Sykes is encouraged by a renewed focus on end market over singular product cycles, but says Waters' execution over the coming two years will be key.

ShowHide Related Items >><<
WAT Waters
$234.15 /

+2.185 (+0.94%)

WAT Waters
$234.15 /

+2.185 (+0.94%)

11/09/20 KeyBanc
Waters initiated with a Sector Weight at KeyBanc
10/28/20 Citi
Waters price target raised to $185 from $180 at Citi
07/29/20 SVB Leerink
Waters price target raised to $225 from $195 at SVB Leerink
07/29/20 Citi
Waters price target raised to $180 from $150 at Citi
WAT Waters
$234.15 /

+2.185 (+0.94%)

WAT Waters
$234.15 /

+2.185 (+0.94%)

Over a week ago
Initiation
Waters initiated with a Sector Weight at KeyBanc » 17:07
11/09/20
11/09
17:07
11/09/20
17:07
WAT

Waters

$230.43 /

+8.17 (+3.68%)

KeyBanc analyst Paul…

KeyBanc analyst Paul Knight initiated coverage of Waters with a Sector Weight rating and $235 price target. The analyst said that, after nearly two decades of beating earnings estimates, Waters has been "routinely" missing expectations and underperforming relative to peers.

ShowHide Related Items >><<
WAT Waters
$230.43 /

+8.17 (+3.68%)

WAT Waters
$230.43 /

+8.17 (+3.68%)

10/28/20 Citi
Waters price target raised to $185 from $180 at Citi
07/29/20 SVB Leerink
Waters price target raised to $225 from $195 at SVB Leerink
07/29/20 Citi
Waters price target raised to $180 from $150 at Citi
07/28/20 JPMorgan
Waters upgraded to Neutral at JPMorgan on limited downside, CEO change
WAT Waters
$230.43 /

+8.17 (+3.68%)

WAT Waters
$230.43 /

+8.17 (+3.68%)

Over a month ago
Recommendations
Waters price target raised to $185 from $180 at Citi » 06:38
10/28/20
10/28
06:38
10/28/20
06:38
WAT

Waters

$224.17 /

+3.785 (+1.72%)

Citi analyst Patrick…

Citi analyst Patrick Donnelly raised the firm's price target on Waters to $185 from $180 and keeps a Sell rating on the shares. While the company's constant currency growth of 2% beat expectations, revenue growth was favorably impacted by delayed purchases from the first half of 2020 that were realized in Q3, Donnelly tells investors in a research note. The analyst believes Waters' gross margins are likely to remain pressured by lower operating leverage, as well as increased investments in the base business to revitalize growth.

ShowHide Related Items >><<
WAT Waters
$224.17 /

+3.785 (+1.72%)

WAT Waters
$224.17 /

+3.785 (+1.72%)

07/29/20 SVB Leerink
Waters price target raised to $225 from $195 at SVB Leerink
07/29/20 Citi
Waters price target raised to $180 from $150 at Citi
07/28/20 JPMorgan
Waters upgraded to Neutral at JPMorgan on limited downside, CEO change
07/28/20 JPMorgan
Waters upgraded to Neutral from Underweight at JPMorgan
WAT Waters
$224.17 /

+3.785 (+1.72%)

WAT Waters
$224.17 /

+3.785 (+1.72%)

Options
Early notable gainers among liquid option names on October 27th » 09:55
10/27/20
10/27
09:55
10/27/20
09:55
HOG

Harley-Davidson

$33.19 /

+4.22 (+14.57%)

, XLNX

Xilinx

$127.76 /

+13.2 (+11.52%)

, FFIV

F5 Networks

$134.13 /

+8.555 (+6.81%)

, LH

LabCorp

$205.00 /

+3.09 (+1.53%)

, WAT

Waters

$225.22 /

+4.84 (+2.20%)

Notable gainers among…

Notable gainers among liquid option names this morning include Harley Davidson (HOG) $34.83 +5.83, Xilinx (XLNX) $124.47 +9.87, F5 Networks (FFIV) $135.75 +10.18, LabCorp (LH) $210.26 +8.30, and Waters (WAT) $228.78 +8.46.

ShowHide Related Items >><<
XLNX Xilinx
$127.76 /

+13.2 (+11.52%)

WAT Waters
$225.22 /

+4.84 (+2.20%)

LH LabCorp
$205.00 /

+3.09 (+1.53%)

HOG Harley-Davidson
$33.19 /

+4.22 (+14.57%)

FFIV F5 Networks
$134.13 /

+8.555 (+6.81%)

HOG Harley-Davidson
$33.19 /

+4.22 (+14.57%)

10/08/20 Wedbush
Harley-Davidson added to Best Ideas List at Wedbush
09/18/20 Wedbush
Demand for new and used Harley-Davidsons 'up considerably,' says Wedbush
09/17/20 Longbow
Harley-Davidson losing share among first-time bike buyers, says Longbow
07/16/20
Fly Intel: Top five analyst upgrades
XLNX Xilinx
$127.76 /

+13.2 (+11.52%)

10/27/20 Susquehanna
Xilinx downgraded to Neutral from Positive at Susquehanna
10/22/20 Wells Fargo
Xilinx price target raised to $110 from $100 at Wells Fargo
10/22/20 Deutsche Bank
Xilinx price target raised to $115 from $100 at Deutsche Bank
10/22/20 Morgan Stanley
Xilinx price target raised to $137 from $117 at Morgan Stanley
FFIV F5 Networks
$134.13 /

+8.555 (+6.81%)

10/23/20 MKM Partners
F5 Networks upgraded to Buy from Neutral at MKM Partners
10/23/20 MKM Partners
F5 Networks upgraded to Buy from Neutral at MKM Partners
10/23/20 MKM Partners
F5 Networks upgraded to Buy from Neutral at MKM Partners
09/18/20 MKM Partners
F5 Networks price target lowered to $140 from $160 at MKM Partners
LH LabCorp
$205.00 /

+3.09 (+1.53%)

10/16/20 Baird
Baird 'pounding the table' on lab stocks after 'favorable' CMS update
10/14/20 Jefferies
LabCorp price target raised to $230 from $183 at Jefferies
10/07/20 Jefferies
FDA expansion of APTIMA's EUA a 'clear endorsement' for Hologic, says Jefferies
08/28/20 Mizuho
Quest, LabCorp weakness yesterday should be bought, says Mizuho
WAT Waters
$225.22 /

+4.84 (+2.20%)

07/29/20 SVB Leerink
Waters price target raised to $225 from $195 at SVB Leerink
07/29/20 Citi
Waters price target raised to $180 from $150 at Citi
07/28/20 JPMorgan
Waters upgraded to Neutral at JPMorgan on limited downside, CEO change
07/28/20 JPMorgan
Waters upgraded to Neutral from Underweight at JPMorgan
XLNX Xilinx
$127.76 /

+13.2 (+11.52%)

WAT Waters
$225.22 /

+4.84 (+2.20%)

LH LabCorp
$205.00 /

+3.09 (+1.53%)

HOG Harley-Davidson
$33.19 /

+4.22 (+14.57%)

FFIV F5 Networks
$134.13 /

+8.555 (+6.81%)

XLNX Xilinx
$127.76 /

+13.2 (+11.52%)

LH LabCorp
$205.00 /

+3.09 (+1.53%)

HOG Harley-Davidson
$33.19 /

+4.22 (+14.57%)

FFIV F5 Networks
$134.13 /

+8.555 (+6.81%)

XLNX Xilinx
$127.76 /

+13.2 (+11.52%)

LH LabCorp
$205.00 /

+3.09 (+1.53%)

HOG Harley-Davidson
$33.19 /

+4.22 (+14.57%)

FFIV F5 Networks
$134.13 /

+8.555 (+6.81%)

XLNX Xilinx
$127.76 /

+13.2 (+11.52%)

WAT Waters
$225.22 /

+4.84 (+2.20%)

LH LabCorp
$205.00 /

+3.09 (+1.53%)

HOG Harley-Davidson
$33.19 /

+4.22 (+14.57%)

FFIV F5 Networks
$134.13 /

+8.555 (+6.81%)

Earnings
Waters sees Q4 revenue down low- to mid-single digit range, consensus $701.49M » 08:26
10/27/20
10/27
08:26
10/27/20
08:26
WAT

Waters

$220.38 /

-1.78 (-0.80%)

Says product launches…

Says product launches have not met expectations. Says lost some momentum in the past few years. Says focused on making changes to regain momentum in the near term. Says market conditions remain variable. Says not in a position to provide detailed guidance. Says delayed purchases from first half were realized in Q3. Sees FY20 operational expenses down 1% to flat. Comments and guidance taken from Q3 earnings conference call.

ShowHide Related Items >><<
WAT Waters
$220.38 /

-1.78 (-0.80%)

WAT Waters
$220.38 /

-1.78 (-0.80%)

07/29/20 SVB Leerink
Waters price target raised to $225 from $195 at SVB Leerink
07/29/20 Citi
Waters price target raised to $180 from $150 at Citi
07/28/20 JPMorgan
Waters upgraded to Neutral at JPMorgan on limited downside, CEO change
07/28/20 JPMorgan
Waters upgraded to Neutral from Underweight at JPMorgan
WAT Waters
$220.38 /

-1.78 (-0.80%)

WAT Waters
$220.38 /

-1.78 (-0.80%)

Earnings
Waters reports Q3 non-GAAP EPS $2.16, consensus $1.93 » 06:54
10/27/20
10/27
06:54
10/27/20
06:54
WAT

Waters

$220.38 /

-1.78 (-0.80%)

Reports Q3 revenue $594M,…

Reports Q3 revenue $594M, consensus $546.49M. "We are pleased with our solid financial results in the third quarter, which were driven by growth across geographies, while we remain cognizant of the ongoing variability we expect to face in our end markets during the fourth quarter," commented Udit Batra, President and CEO. "Since joining the Company, I have been working diligently to assess Waters' overall positioning and to identify key areas in need of improvement. I believe that Waters has established a solid foundation for growth and that we must now turn our focus to improving the consistency of our commercial execution and product development efforts. We will move swiftly, but deliberately, to reinvigorate our business and address those areas in which Waters has underperformed."

ShowHide Related Items >><<
WAT Waters
$220.38 /

-1.78 (-0.80%)

WAT Waters
$220.38 /

-1.78 (-0.80%)

07/29/20 SVB Leerink
Waters price target raised to $225 from $195 at SVB Leerink
07/29/20 Citi
Waters price target raised to $180 from $150 at Citi
07/28/20 JPMorgan
Waters upgraded to Neutral at JPMorgan on limited downside, CEO change
07/28/20 JPMorgan
Waters upgraded to Neutral from Underweight at JPMorgan
WAT Waters
$220.38 /

-1.78 (-0.80%)

WAT Waters
$220.38 /

-1.78 (-0.80%)

Options
Early notable gainers among liquid option names on October 13th » 09:55
10/13/20
10/13
09:55
10/13/20
09:55
WAT

Waters

$209.32 /

+7.16 (+3.54%)

, EOG

EOG Resources

$39.34 /

+1.13 (+2.96%)

, BLK

BlackRock

$637.00 /

+21.59 (+3.51%)

, XEC

Cimarex Energy

$25.74 /

+0.965 (+3.90%)

, DIS

Disney

$129.30 /

+4.33 (+3.46%)

Notable gainers among…

Notable gainers among liquid option names this morning include Waters (WAT) $210.25 +8.12, EOG Resources (EOG) $39.70 +1.49, BlackRock (BLK) $638.11 +23.22, Cimarex Energy (XEC) $25.69 +0.92, and Disney (DIS) $129.54 +4.58.

ShowHide Related Items >><<
XEC Cimarex Energy
$25.74 /

+0.965 (+3.90%)

WAT Waters
$209.32 /

+7.16 (+3.54%)

EOG EOG Resources
$39.34 /

+1.13 (+2.96%)

DIS Disney
$129.30 /

+4.33 (+3.46%)

BLK BlackRock
$637.00 /

+21.59 (+3.51%)

WAT Waters
$209.32 /

+7.16 (+3.54%)

07/29/20 SVB Leerink
Waters price target raised to $225 from $195 at SVB Leerink
07/29/20 Citi
Waters price target raised to $180 from $150 at Citi
07/28/20 JPMorgan
Waters upgraded to Neutral at JPMorgan on limited downside, CEO change
07/28/20 JPMorgan
Waters upgraded to Neutral from Underweight at JPMorgan
EOG EOG Resources
$39.34 /

+1.13 (+2.96%)

10/01/20 Truist
EOG Resources price target lowered to $61 from $70 at Truist
09/14/20 Northland
EOG Resources initiated with a Market Perform at Northland
08/04/20 Credit Suisse
EOG Resources assumed with an Outperform at Credit Suisse
07/23/20
Fly Intel: Top five analyst downgrades
BLK BlackRock
$637.00 /

+21.59 (+3.51%)

10/08/20 Wells Fargo
BlackRock price target raised to $655 from $645 at Wells Fargo
10/01/20
Fly Intel: Top five analyst upgrades
10/01/20 Deutsche Bank
BlackRock upgraded to Buy on ESG growth potential at Deutsche Bank
09/30/20 Deutsche Bank
BlackRock upgraded to Buy from Hold at Deutsche Bank
XEC Cimarex Energy
$25.74 /

+0.965 (+3.90%)

10/13/20 Truist
Cimarex Energy upgraded to Buy from Hold at Truist
10/13/20 Truist
Cimarex Energy upgraded to Buy from Hold at Truist
09/28/20 BofA
Cimarex Energy upgraded to Buy from Neutral at BofA
09/14/20 Wells Fargo
Cimarex Energy upgraded to Overweight from Equal Weight at Wells Fargo
DIS Disney
$129.30 /

+4.33 (+3.46%)

10/13/20
Fly Intel: Top five analyst upgrades
10/13/20 RBC Capital
EPR Properties downgraded to Sector Perform from Outperform at RBC Capital
10/13/20 Morgan Stanley
Disney reorg 'leaves little doubt' about DTC commitment, says Morgan Stanley
10/13/20 Loop Capital
Disney upgraded to Buy from Hold at Loop Capital
XEC Cimarex Energy
$25.74 /

+0.965 (+3.90%)

WAT Waters
$209.32 /

+7.16 (+3.54%)

EOG EOG Resources
$39.34 /

+1.13 (+2.96%)

DIS Disney
$129.30 /

+4.33 (+3.46%)

BLK BlackRock
$637.00 /

+21.59 (+3.51%)

  • 13
    May
XEC Cimarex Energy
$25.74 /

+0.965 (+3.90%)

DIS Disney
$129.30 /

+4.33 (+3.46%)

BLK BlackRock
$637.00 /

+21.59 (+3.51%)

DIS Disney
$129.30 /

+4.33 (+3.46%)

BLK BlackRock
$637.00 /

+21.59 (+3.51%)

XEC Cimarex Energy
$25.74 /

+0.965 (+3.90%)

WAT Waters
$209.32 /

+7.16 (+3.54%)

EOG EOG Resources
$39.34 /

+1.13 (+2.96%)

DIS Disney
$129.30 /

+4.33 (+3.46%)

BLK BlackRock
$637.00 /

+21.59 (+3.51%)

Over a quarter ago
Conference/Events
Waters participates in a conference call hosted by BTIG » 11:25
08/03/20
08/03
11:25
08/03/20
11:25
WAT

Waters

$215.67 /

+2.88 (+1.35%)

BTIG Life Science &…

BTIG Life Science & Diagnostic Tools Analyst Nam holds a conference call with management to provide a 2Q20 update on August 3 at 12 pm.

ShowHide Related Items >><<
WAT Waters
$215.67 /

+2.88 (+1.35%)

WAT Waters
$215.67 /

+2.88 (+1.35%)

07/29/20 SVB Leerink
Waters price target raised to $225 from $195 at SVB Leerink
07/29/20 Citi
Waters price target raised to $180 from $150 at Citi
07/28/20 JPMorgan
Waters upgraded to Neutral at JPMorgan on limited downside, CEO change
07/28/20 JPMorgan
Waters upgraded to Neutral from Underweight at JPMorgan
WAT Waters
$215.67 /

+2.88 (+1.35%)

WAT Waters
$215.67 /

+2.88 (+1.35%)

WAT Waters
$215.67 /

+2.88 (+1.35%)

Conference/Events
Waters participates in a conference call hosted by BTIG » 04:55
08/03/20
08/03
04:55
08/03/20
04:55
WAT

Waters

$212.79 /

+0.11 (+0.05%)

BTIG Life Science &…

BTIG Life Science & Diagnostic Tools Analyst Nam holds a conference call with management to provide a 2Q20 update on August 3 at 12 pm.

ShowHide Related Items >><<
WAT Waters
$212.79 /

+0.11 (+0.05%)

WAT Waters
$212.79 /

+0.11 (+0.05%)

07/29/20 SVB Leerink
Waters price target raised to $225 from $195 at SVB Leerink
07/29/20 Citi
Waters price target raised to $180 from $150 at Citi
07/28/20 JPMorgan
Waters upgraded to Neutral at JPMorgan on limited downside, CEO change
07/28/20 JPMorgan
Waters upgraded to Neutral from Underweight at JPMorgan
WAT Waters
$212.79 /

+0.11 (+0.05%)

WAT Waters
$212.79 /

+0.11 (+0.05%)

WAT Waters
$212.79 /

+0.11 (+0.05%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.